Public market insider buying at Kane Biotech (V:KNE)

Richard J. Renaud, a 10% Holder, acquired 3,125,000 Common Shares on a direct ownership basis at a price of $0.080 on September 11th, 2023. This represents a $250,000 investment into the company's shares and an account share holdings change of 27.2%.

Kane Biotech is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.